Integral Health Asset Management, LLC - Q3 2021 holdings

$348 Million is the total value of Integral Health Asset Management, LLC's 70 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 71.8% .

 Value Shares↓ Weighting
ARNA BuyARENA PHARMACEUTICALS INC$17,865,000
+16.4%
300,000
+33.3%
5.14%
+21.6%
ACHC SellACADIA HEALTHCARE COMPANY IN$16,264,000
-0.3%
255,000
-1.9%
4.68%
+4.1%
SAGE BuySAGE THERAPEUTICS INC$14,135,000
+11.1%
319,000
+42.4%
4.06%
+16.0%
CVS NewCVS HEALTH CORP$12,729,000150,000
+100.0%
3.66%
CYTK SellCYTOKINETICS INC$11,616,000
-16.1%
325,000
-53.6%
3.34%
-12.5%
GMED BuyGLOBUS MED INCcl a$11,493,000
+14.0%
150,000
+15.4%
3.30%
+19.1%
PFE NewPFIZER INC$10,753,000250,000
+100.0%
3.09%
BPMC SellBLUEPRINT MEDICINES CORP$10,075,000
+14.5%
98,000
-2.0%
2.90%
+19.6%
MDT  MEDTRONIC PLC$10,028,000
+1.0%
80,0000.0%2.88%
+5.4%
NVST BuyENVISTA HOLDINGS CORPORATION$9,616,000
+23.6%
230,000
+27.8%
2.76%
+29.1%
ANTM SellANTHEM INC$9,320,000
-51.2%
25,000
-50.0%
2.68%
-49.0%
HOLX NewHOLOGIC INC$8,857,000120,000
+100.0%
2.55%
ZBH BuyZIMMER BIOMET HOLDINGS INC$8,782,000
+56.0%
60,000
+71.4%
2.52%
+62.9%
PKI BuyPERKINELMER INC$8,665,000
+40.3%
50,000
+25.0%
2.49%
+46.5%
SGEN NewSEAGEN INC$6,792,00040,000
+100.0%
1.95%
NTLA BuyINTELLIA THERAPEUTICS INC$6,708,000
+38.1%
50,000
+66.7%
1.93%
+44.2%
HZNP NewHORIZON THERAPEUTICS PUB L$6,572,00060,000
+100.0%
1.89%
APLS BuyAPELLIS PHARMACEUTICALS INC$6,262,000
+183.1%
190,000
+442.9%
1.80%
+195.6%
CNC NewCENTENE CORP DEL$6,231,000100,000
+100.0%
1.79%
REGN SellREGENERON PHARMACEUTICALS$6,052,000
-41.4%
10,000
-45.9%
1.74%
-38.8%
ZNTL SellZENTALIS PHARMACEUTICALS INC$5,998,000
-9.8%
90,000
-28.0%
1.72%
-5.8%
FATE BuyFATE THERAPEUTICS INC$5,631,000
-18.9%
95,000
+18.8%
1.62%
-15.3%
DXCM NewDEXCOM INC$5,469,00010,000
+100.0%
1.57%
CCXI BuyCHEMOCENTRYX INC$5,130,000
+119.0%
300,000
+71.4%
1.48%
+128.7%
LFST NewLIFESTANCE HEALTH GROUP INC$5,075,000350,000
+100.0%
1.46%
ABC SellAMERISOURCEBERGEN CORP$4,778,000
-40.4%
40,000
-42.9%
1.37%
-37.7%
ALNY  ALNYLAM PHARMACEUTICALS INC$4,720,000
+11.4%
25,0000.0%1.36%
+16.3%
AGL BuyAGILON HEALTH INC$4,718,000
+16.3%
180,000
+80.0%
1.36%
+21.4%
NTRA SellNATERA INC$4,458,000
-28.6%
40,000
-27.3%
1.28%
-25.4%
RLAY BuyRELAY THERAPEUTICS INC$4,414,000
+0.5%
140,000
+16.7%
1.27%
+5.0%
HRTX BuyHERON THERAPEUTICS INC$4,383,000
+182.4%
410,000
+310.0%
1.26%
+195.1%
UHS SellUNIVERSAL HLTH SVCS INCcl b$4,151,000
-56.4%
30,000
-53.8%
1.19%
-54.5%
ARCT NewARCTURUS THERAPEUTICS HLDGS$4,061,00085,000
+100.0%
1.17%
FOLD SellAMICUS THERAPEUTICS INC$4,059,000
-11.4%
425,000
-10.5%
1.17%
-7.5%
EW SellEDWARDS LIFESCIENCES CORP$3,962,000
-41.1%
35,000
-46.2%
1.14%
-38.5%
DNLI SellDENALI THERAPEUTICS INC$3,784,000
-40.4%
75,000
-7.4%
1.09%
-37.8%
ABBV NewABBVIE INC$3,775,00035,000
+100.0%
1.08%
SIBN BuySI-BONE INC$3,641,000
+28.6%
170,000
+88.9%
1.05%
+34.2%
PTCT SellPTC THERAPEUTICS INC$3,613,000
-22.4%
97,100
-11.8%
1.04%
-18.9%
ATRA NewATARA BIOTHERAPEUTICS INC$3,580,000200,000
+100.0%
1.03%
NewAVALO THERAPEUTICS INC$3,543,0001,625,000
+100.0%
1.02%
MRTX SellMIRATI THERAPEUTICS INC$3,538,000
-56.2%
20,000
-60.0%
1.02%
-54.3%
RETA SellREATA PHARMACEUTICALS INCcl a$3,521,000
-40.8%
35,000
-16.7%
1.01%
-38.1%
NVRO SellNEVRO CORP$3,491,000
-44.6%
30,000
-21.1%
1.00%
-42.1%
MGNX NewMACROGENICS INC$3,350,000160,000
+100.0%
0.96%
ACRS BuyACLARIS THERAPEUTICS INC$3,330,000
+8.4%
185,000
+5.7%
0.96%
+13.1%
AERI SellAERIE PHARMACEUTICALS INC$2,850,000
-56.6%
250,000
-39.0%
0.82%
-54.7%
BHVN NewBIOHAVEN PHARMACTL HLDG CO L$2,778,00020,000
+100.0%
0.80%
INSM NewINSMED INC$2,754,000100,000
+100.0%
0.79%
REPL  REPLIMUNE GROUP INC$2,668,000
-22.8%
90,0000.0%0.77%
-19.4%
INSP NewINSPIRE MED SYS INC$2,329,00010,000
+100.0%
0.67%
RGNX NewREGENXBIO INC$2,306,00055,000
+100.0%
0.66%
ZY NewZYMERGEN INC$2,107,000160,000
+100.0%
0.61%
LYEL NewLYELL IMMUNOPHARMA INC$2,072,000140,000
+100.0%
0.60%
AKRO  AKERO THERAPEUTICS INC$1,900,000
-9.9%
85,0000.0%0.55%
-6.0%
IMGN NewIMMUNOGEN INC$1,701,000300,000
+100.0%
0.49%
LXRX NewLEXICON PHARMACEUTICALS INC$1,684,000350,000
+100.0%
0.48%
MYOV SellMYOVANT SCIENCES LTD$1,459,000
-24.6%
65,000
-23.5%
0.42%
-21.4%
ZYME NewZYMEWORKS INC$1,452,00050,000
+100.0%
0.42%
DTIL SellPRECISION BIOSCIENCES INC$1,443,000
-34.1%
125,000
-28.6%
0.42%
-31.2%
RVNC NewREVANCE THERAPEUTICS INC$1,393,00050,000
+100.0%
0.40%
BMRN SellBIOMARIN PHARMACEUTICAL INC$1,391,000
-33.3%
18,000
-28.0%
0.40%
-30.3%
FMTX BuyFORMA THERAPEUTICS HLDGS INC$1,391,000
+24.2%
60,000
+33.3%
0.40%
+29.9%
KURA SellKURA ONCOLOGY INC$1,124,000
-23.0%
60,000
-14.3%
0.32%
-19.7%
AVIR NewATEA PHARMACEUTICALS INC$1,052,00030,000
+100.0%
0.30%
AGIO SellAGIOS PHARMACEUTICALS INC$923,000
-44.2%
20,000
-33.3%
0.26%
-41.8%
MGTA BuyMAGENTA THERAPEUTICS INC$655,000
-10.8%
90,000
+20.0%
0.19%
-6.9%
PTGX NewPROTAGONIST THERAPEUTICS INC$620,00035,000
+100.0%
0.18%
CMRX BuyCHIMERIX INC$557,000
-7.2%
90,000
+20.0%
0.16%
-3.0%
LBPH  LONGBOARD PHARMACEUTICALS IN$266,000
-2.9%
30,0000.0%0.08%
+1.3%
ARDX ExitARDELYX INC$0-70,000
-100.0%
-0.15%
ALEC ExitALECTOR INC$0-35,000
-100.0%
-0.20%
KDMN ExitKADMON HLDGS INC$0-225,000
-100.0%
-0.24%
MSON ExitMISONIX INC$0-45,000
-100.0%
-0.28%
ExitTRILLIUM THERAPEUTICS INC$0-150,000
-100.0%
-0.40%
AXGN ExitAXOGEN INC$0-70,000
-100.0%
-0.42%
KPTI ExitKARYOPHARM THERAPEUTICS INC$0-150,000
-100.0%
-0.43%
ALT ExitALTIMMUNE INC$0-160,000
-100.0%
-0.43%
ONEM Exit1LIFE HEALTHCARE INC$0-50,000
-100.0%
-0.46%
MCRB ExitSERES THERAPEUTICS INC$0-75,000
-100.0%
-0.49%
BCRX ExitBIOCRYST PHARMACEUTICALS INC$0-125,000
-100.0%
-0.54%
UNH ExitUNITEDHEALTH GROUP INC$0-5,000
-100.0%
-0.55%
CERC ExitCERECOR INC$0-675,000
-100.0%
-0.61%
AXNX ExitAXONICS INC$0-40,000
-100.0%
-0.70%
IRTC ExitIRHYTHM TECHNOLOGIES INC$0-50,000
-100.0%
-0.91%
ALKS ExitALKERMES PLC$0-150,000
-100.0%
-1.01%
PNTG ExitPENNANT GROUP INC$0-90,000
-100.0%
-1.01%
BNTX ExitBIONTECH SEsponsored ads$0-17,000
-100.0%
-1.05%
DHR ExitDANAHER CORPORATION$0-15,000
-100.0%
-1.11%
ZLAB ExitZAI LAB LTDadr$0-25,000
-100.0%
-1.22%
ACCD ExitACCOLADE INC$0-100,000
-100.0%
-1.50%
A ExitAGILENT TECHNOLOGIES INC$0-40,000
-100.0%
-1.63%
TFX ExitTELEFLEX INCORPORATED$0-20,000
-100.0%
-2.21%
LHCG ExitLHC GROUP INC$0-42,000
-100.0%
-2.32%
SNY ExitSANOFIsponsored adr$0-175,000
-100.0%
-2.54%
BIIB ExitBIOGEN INC$0-35,000
-100.0%
-3.34%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CYTOKINETICS INC15Q3 20234.7%
SAGE THERAPEUTICS INC15Q2 20235.0%
BIOMARIN PHARMACEUTICAL INC15Q2 20234.1%
ENVISTA HOLDINGS CORPORATION14Q3 20234.0%
AKERO THERAPEUTICS INC14Q3 20231.5%
REVVITY INC13Q3 20234.2%
BLUEPRINT MEDICINES CORP13Q3 20233.3%
PTC THERAPEUTICS INC13Q2 20231.7%
ELEVANCE HEALTH INC12Q3 20236.7%
NEVRO CORP12Q4 20224.5%

View Integral Health Asset Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-09
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-03
13F-HR2022-05-12
13F-HR2022-02-02
13F-HR2021-11-12

View Integral Health Asset Management, LLC's complete filings history.

Compare quarters

Export Integral Health Asset Management, LLC's holdings